Related Experiment Video
Updated: Mar 20, 2026
09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
918
Drug-Eluting Resorbable Scaffolds: Design Considerations and Clinical Data
Mary Beth Kossuth1, Richard J Rapoza1
1Abbott Vascular, Santa Clara, CA, USA.
Interventional Cardiology Clinics
|March 18, 2026
Summary
Drug-eluting resorbable scaffolds offer a temporary solution for vascular intervention, combining angioplasty and stenting benefits. These devices support healing and degrade naturally, restoring vessel function without permanent implants.
Area of Science:
- Biomaterials Science
- Cardiovascular Medicine
- Medical Devices
Background:
- Percutaneous vascular interventions traditionally use balloon angioplasty or drug-eluting stents.
- These methods can leave permanent implants, potentially causing long-term complications.
- There is a need for transient devices that support vessel healing and then disappear.
Purpose of the Study:
- To introduce drug-eluting resorbable scaffolds as an advancement in vascular intervention.
- To highlight the 'leave nothing behind' principle of these transient devices.
- To discuss the development and clinical evaluation of these innovative scaffolds.
Main Methods:
- Engineering resorbable scaffolds with tailored material degradation kinetics.
- Integrating drug-eluting capabilities for localized therapeutic delivery.
- Conducting clinical studies in coronary and peripheral artery disease.
Main Results:
- Drug-eluting resorbable scaffolds provide temporary mechanical support and facilitate vascular healing.
- These devices degrade benignly, restoring natural vessel function.
- Second-generation devices show improvements and are under clinical evaluation or approved.
Conclusions:
- Drug-eluting resorbable scaffolds represent a significant advancement, merging angioplasty and stenting benefits.
- The transient nature of these scaffolds promotes natural vessel function restoration.
- Ongoing clinical evaluation and approvals indicate the clinical viability of these devices.
